CAITLIN MENGLER: Open Payments
NPI 1245599513 · N CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 61 payments from 32 companies in 2025. Trend: 2023 $946 · 2024 $968 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $199 |
| PFIZER INC. | 4 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $89 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Gilead Sciences, Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $51 |
| BeOne Medicines USA, Inc. | 2 | $46 |
| SOBI, INC | 2 | $41 |
Products named: KISQALI, OPDIVO, OJJAARA, Trodelvy, KEYTRUDA, DATROWAY, SCEMBLIX, PLUVICTO.
Industry payments across SC — which companies pay providers there.
